Unveiling the mysteries: Functional insights into hypothetical proteins from 638R.

Humans benefit from a vast community of microorganisms in their gastrointestinal tract, known as the gut microbiota, numbering in the tens of trillions. An imbalance in the gut microbiota known as dysbiosis, can lead to changes in the metabolite profile, elevating the levels of toxins like toxin (BFT), colibactin, and cytolethal distending toxin. These toxins are implicated in the process of oncogenesis.